Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity

被引:47
|
作者
Hidaka, M [1 ]
Fujita, K [1 ]
Ogikubo, T [1 ]
Yamasaki, K [1 ]
Iwakiri, T [1 ]
Okumura, M [1 ]
Kodama, H [1 ]
Arimori, K [1 ]
机构
[1] Miyazaki Med Coll Hosp, Dept Pharm, Kiyotake, Miyazaki 8891692, Japan
关键词
D O I
10.1124/dmd.32.6.581
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There has been very limited information on the capacities of tropical fruits to inhibit human cytochrome P450 3A (CYP3A) activity. Thus, the inhibitory effects of tropical fruits on midazolam 1'-hydroxylase activity of CYP3A in human liver microsomes were evaluated. Eight tropical fruits such as common papaw, dragon fruit, kiwi fruit, mango, passion fruit, pomegranate, rambutan, and star fruit were tested. We also examined the inhibition of CYP3A activity by grapefruit ( white) and Valencia orange as controls. The juice of star fruit showed the most potent inhibition of CYP3A. The addition of a star fruit juice (5.0%, v/v) resulted in the almost complete inhibition of midazolam 1'-hydroxylase activity (residual activity of 0.1%). In the case of grapefruit, the residual activity was 14.7%. The inhibition depended on the amount of fruit juice added to the incubation mixture (0.2-6.0%, v/v). The elongation of the preincubation period of a juice from star fruit (1.25 or 2.5%, v/v) with the microsomal fraction did not alter the CYP3A inhibition, suggesting that the star fruit did not contain a mechanism-based inhibitor. Thus, we discovered filtered extracts of star fruit juice to be inhibitors of human CYP3A activity in vitro.
引用
收藏
页码:581 / 583
页数:3
相关论文
共 50 条
  • [31] Cytochrome P450 3A and their regulation
    Oliver Burk
    Leszek Wojnowski
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 369 : 105 - 124
  • [32] A non-destructive BFCOD assay for in vivo measurement of cytochrome P450 3A (CYP3A) enzyme activity in fish embryos and larvae
    Elias M. Oziolor
    Alexis N. Carey
    Cole W. Matson
    Ecotoxicology, 2017, 26 : 809 - 819
  • [33] A non-destructive BFCOD assay for in vivo measurement of cytochrome P450 3A (CYP3A) enzyme activity in fish embryos and larvae
    Oziolor, Elias M.
    Carey, Alexis N.
    Matson, Cole W.
    ECOTOXICOLOGY, 2017, 26 (06) : 809 - 819
  • [34] Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes:: Comparison of KI values and impact of CYP3A5 expression
    Gibbs, MA
    Thummel, KE
    Shen, DD
    Kunze, KL
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (02) : 180 - 187
  • [35] Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism:: the effect of assay conditions and regioselective stimulation by α-naphthoflavone, terfenadine and testosterone
    Maenpaa, J
    Hall, SD
    Ring, BJ
    Strom, SC
    Wrighton, SA
    PHARMACOGENETICS, 1998, 8 (02): : 137 - 155
  • [36] Characterization of equine cytochrome P450: role of CYP3A in the metabolism of diazepam
    Nakayama, S. M. M.
    Ikenaka, Y.
    Hayami, A.
    Mizukawa, H.
    Darwish, W. S.
    Watanabe, K. P.
    Kawai, Y. K.
    Ishizuka, M.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2016, 39 (05) : 478 - 487
  • [37] Induction of intestinal cytochrome P450 (CYP3A) by rifampicin in beagle dogs
    Kyokawa, Y
    Nishibe, Y
    Wakabayashi, M
    Harauchi, T
    Maruyama, T
    Baba, T
    Ohno, K
    CHEMICO-BIOLOGICAL INTERACTIONS, 2001, 134 (03) : 291 - 305
  • [38] Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib
    Morcos, Peter N.
    Cleary, Yumi
    Guerini, Elena
    Dall, Georgina
    Bogman, Katrijn
    De Petris, Luigi
    Viteri, Santiago
    Bordogna, Walter
    Yu, Li
    Martin-Facklam, Meret
    Phipps, Alex
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (03): : 280 - 291
  • [39] RENAL AND HEPATIC FAMILY 3A CYTOCHROMES P450 (CYP3A) IN SPONTANEOUSLY HYPERTENSIVE RATS
    GHOSH, SS
    BASU, AK
    GHOSH, S
    HAGLEY, R
    KRAMER, L
    SCHUETZ, J
    GROGAN, WM
    GUZELIAN, P
    WATLINGTON, CO
    BIOCHEMICAL PHARMACOLOGY, 1995, 50 (01) : 49 - 54
  • [40] Inhibition of hepatic cytochrome P450 isoform, CYP3A, by 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors
    Ikeda, T
    Ishigami, M
    Komai, T
    Yamazoe, Y
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 135 - 135